基于门静脉重建方案的肝移植围术期门静脉血栓处理策略

doi:10.16139/j.1007-9610.2018.03.002

摘要/Abstract

中图分类号:

R657.3

滕飞, 傅志仁. 基于门静脉重建方案的肝移植围术期门静脉血栓处理策略[J]. 外科理论与实践, 2018, 23(03): 191-195.

[1] Hibi T, Nishida S, Levi DM, et al.When and why portal vein thrombosis matters in liver transplantation: a critical audit of 174 cases[J]. Ann Surg,2014,259(4):760-766.
[2] Yerdel MA, Gunson B, Mirza D, et al.Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome[J]. Transplantation,2000,69(9):1873-1881.
[3] Sogaard KK, Horvath-Puho E, Gronbaek H, et al.Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study[J]. Am J Gastroenterol,2009,104(1):96-101.
[4] Francoz C, Valla D, Durand F.Portal vein thrombosis, cirrhosis, and liver transplantation[J]. J Hepatol,2012,57(1):203-212.
[5] Fukui H, Saito H, Ueno Y, et al.Evidence-based clinical practice guidelines for liver cirrhosis 2015[J]. J Gastroenterol,2016,51(7):629-650.
[6] Ghabril M, Agarwal S, Lacerda M, et al.Portal vein thrombosis is a risk factor for poor early outcomes after liver transplantation: analysis of risk factors and outcomes for portal vein thrombosis in waitlisted patients[J]. Transplantation,2016,100(1):126-133.
[7] Bezinover D, Reeder E, Aziz F, et al.African Americans have a lower prevalence of portal vein thrombosis at the time of liver transplantation[J]. HPB (Oxford),2017,19(7):620-628.
[8] Bezinover D, Iskandarani K, Chinchilli V, et al.Autoimmune conditions are associated with perioperative thrombotic complications in liver transplant recipients: A UNOS database analysis[J]. BMC Anesthesiol,2016,16(1):26.
[9] Montenovo M, Rahnemai-Azar A, Reyes J, et al.Clinical impact and risk factors of portal vein thrombosis for patients on wait list for liver transplant[J]. Exp Clin Transplant,2017,16(2):166-171.
[10] Bagheri Lankarani K, Homayon K, Motevalli D, et al.Risk factors for portal vein thrombosis in patients with cirrhosis awaiting liver transplantation in Shiraz, Iran[J]. Hepat Mon,2015,15(12): e26407.
[11] Hongwei C, Zhang L, Maoping L, et al.Era of liver transplantation: combined anatomic splenectomy and anticoagulant therapy in prevention of portal vein thrombosis after splenectomy[J]. Hepatogastroenterology,2015,62(138):405-409.
[12] Pan C, Shi Y, Zhang JJ, et al.Single-center experience of 253 portal vein thrombosis patients undergoing liver transplantation in China[J]. Transplant Proc,2009,41(9):3761-3765.
[13] Salem R, Vouche M, Baker T, et al.Pretransplant portal vein recanalization-transjugular intrahepatic portosyste-mic shunt in patients with complete obliterative portal vein thrombosis[J]. Transplantation,2015,99(11):2347-2355.
[14] Boyer TD, Haskal ZJ.The Role of transjugular intrahe-patic portosystemic shunt(TIPS) in the management of portal hypertension: update 2009[J]. Hepatology,2010,51(1):306.
[15] Piangatelli C, Faloia L, Cristiani C, et al.Point of care perioperative coagulation management in liver transplantation and complete portal vein thrombosis[J]. Case Rep Transplant,2014,2014:487364.
[16] Rodriguez-Castro KI, Porte RJ, Nadal E, et al.Management of nonneoplastic portal vein thrombosis in the setting of liver transplantation: a systematic review[J]. Transplantation,2012,94(11):1145-1153.
[17] Hwang HP, Yang JD, Bae SI, et al.Usefulness of artificial jump graft to portal vein thrombosis in deceased donor liver transplantation[J]. Yonsei Med J,2015,56(2):586-590.
[18] Llado L, Fabregat J, Castellote J, et al.Management of portal vein thrombosis in liver transplantation: influence on morbidity and mortality[J]. Clin Transplant,2007,21(6):716-721.
[19] Chen TH, Jeng LB, Lee CC, et al.Polytetrafluoroethylene patch venoplasty for outflow reconstruction in living donor liver transplantation: two case reports[J]. Transplant Proc,2008,40(8):2529-2530.
[20] Moon DB, Lee SG, Ahn CS, et al.Section 6. Management of extensive nontumorous portal vein thrombosis in adult living donor liver transplantation[J]. Transplantation,2014, 97(Suppl 8):S23-S30.
[21] Tzakis AG, Kirkegaard P, Pinna AD, et al.Liver transplantation with cavoportal hemitransposition in the pre-sence of diffuse portal vein thrombosis[J]. Transplantation,1998,65(5):619-624.
[22] Bhangui P, Lim C, Salloum C, et al.Caval inflow to the graft for liver transplantation in patients with diffuse portal vein thrombosis: a 12-year experience[J]. Ann Surg,2011,254(6):1008-1016.
[23] Nazzal M, Sun Y, Okoye O, et al.Reno-portal shunt for liver transplant, an alternative inflow for recipients with gradeⅢ-Ⅳ portal vein thrombosis: Tips for a better outcome[J]. Int J Surg Case Rep,2017,41:251-254.
[24] Settmacher U, Stange B, Schaser KD, et al.Primary permanent arterialization of the portal vein in liver transplantation[J]. Transpl Int,2003,16(6):430-433.
[25] Nivatvongs S, Sirijindakul B, Nontasoot B.Portal vein arterialization for liver transplantation with extensive portomesenteric vein thrombosis: a case report[J]. Transplant Proc,2004,36(8):2267-2268.
[26] Paloyo S, Nishida S, Fan J, et al.Portal vein arterialization using an accessory right hepatic artery in liver transplantation[J]. Liver Transpl,2013,19(7):773-775.
[27] Ott R, Bohner C, Muller S, et al.Outcome of patients with pre-existing portal vein thrombosis undergoing arterialization of the portal vein during liver transplantation[J]. Transpl Int,2003,16(1):15-20.
[28] Vianna RM, Mangus RS, Kubal C, et al.Multivisceral transplantation for diffuse portomesenteric thrombosis[J]. Ann Surg,2012,255(6):1144-1150.
[29] Stine JG, Pelletier SJ, Schmitt TM, et al.Pre-transplant portal vein thrombosis is an independent risk factor for graft loss due to hepatic artery thrombosis in liver transplant recipients[J]. HPB(Oxford),2016,18(3):279-286.
[30] Stine JG, Argo CK, Pelletier SJ, et al.Liver transplant recipients with portal vein thrombosis receiving an organ from a high-risk donor are at an increased risk for graft loss due to hepatic artery thrombosis[J]. Transpl Int,2016, 29(12):1286-1295.
[31] Kensinger CD, Sexton KW, Baron CM, et al.Management of portal vein thrombosis after liver transplantation with a combined open and endovascular approach[J]. Liver Transpl,2015,21(1):132-134.
[32] Pulitano C, Rogan C, Sandroussi C, et al.Percutaneous retroperitoneal splenorenal shunt for symptomatic portal vein thrombosis after liver transplantation[J]. Am J Transplant,2015,15(8):2261-2264.

基于门静脉重建方案的肝移植围术期门静脉血栓处理策略

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

[1]	杨雪, 刘锦, 王铮, 陶杰, 郝杰, 李宇, 孙昊. 他克莫司降低肝移植病人ERCP术后胰腺炎发生的临床观察[J]. 外科理论与实践, 2022, 27(3): 253-255.
[2]	黄纪伟, 邱国腾, 曾勇. 肝细胞癌外科治疗进展[J]. 外科理论与实践, 2022, 27(02): 113-118.
[3]	冯浩, 吕子成, 夏强. 肝癌肝移植全过程管理及治疗进展[J]. 外科理论与实践, 2022, 27(02): 119-122.
[4]	吴浩翔, 吕子成, 侯宇宸, 张子杰, 乔子耘, 冯浩, 夏强. 儿童肝移植中他克莫司浓度个体内变异[J]. 外科理论与实践, 2022, 27(02): 145-151.
[5]	张磊, 毛家玺, 李涛, 滕飞, 孙克彦. 术前免疫炎症反应对原发性胆汁性胆管炎肝移植病人预后影响的双中心回顾性研究[J]. 外科理论与实践, 2022, 27(02): 158-164.
[6]	李涛, 陈皓. 肝硬化门静脉高压症的肝移植治疗[J]. 外科理论与实践, 2021, 26(03): 189-194.
[7]	戚德彬, 陈鹏, 佟辉, 彭承宏, 李涛. 肝移植术后撤除免疫抑制剂的回顾性分析[J]. 外科理论与实践, 2021, 26(03): 231-235.
[8]	黄成, 孙惠川. 《原发性肝癌诊疗规范（2019年版）》肝脏外科领域更新的展望[J]. 外科理论与实践, 2020, 25(01): 6-9.
[9]	佟辉, 陈鹏, 张家强, 谢俊杰, 李涛, 祝哲诚, 彭承宏. 加速康复外科在肝癌肝移植中的临床应用[J]. 外科理论与实践, 2020, 25(01): 45-49.
[10]	宫钰, 胡志强, 黄晓武. 肝移植术后移植物抗宿主病[J]. 外科理论与实践, 2018, 23(03): 196-199.
[11]	佟辉, 张家强, 祝哲诚, 彭承宏, 李涛. 超“UCSF标准”肝细胞癌肝移植术前经肝动脉化疗栓塞的疗效[J]. 外科理论与实践, 2018, 23(03): 241-246.
[12]	李涛, 祝哲诚, 彭承宏. 肝移植“精准”治疗原发性肝脏恶性肿瘤[J]. 外科理论与实践, 2018, 23(03): 200-204.
[13]	李甫, 张晞文,. 肝移植术后胆管狭窄介入诊疗的进展[J]. 外科理论与实践, 2017, 22(06): 538-541.
[14]	吴性江, 曹建民, 范鑫欣, 丁威威, 何长生, 刘宝晨,. TIPS治疗慢性门静脉血栓伴食管曲张静脉出血的临床疗效[J]. 外科理论与实践, 2016, 21(05): 389-394.
[15]	叶啟发, 曾宪鹏,. 自体肝移植及其技术改进[J]. 外科理论与实践, 2016, 21(03): 188-191.